Jindal, T., Cai, E. Y., Reyes, K. R., Jiang, C. Y., Thomas, Z., Jang, A., Zhong, J. Y., Alhalabi, O., Campbell, M. T., Koshkin, V. S., Brown, J. R. (2026). Predictive value of early circulating tumor DNA (ctDNA) response in advanced urothelial carcinoma (aUC) treated with enfortumab vedotin plus pembrolizumab (EVP).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.800